9001-29-0

Basic information

• Product Name: ANTIHEMOPHILIC FACTOR C, HUMAN
• Synonyms: COAGULATION FACTOR X, HUMAN PLASMA;HUMAN FACTOR X;FACTOR X (BOVINE);FACTOR X (HUMAN);STUART-POWER FACTOR, HUMAN;STUART PROWER FACTOR;STUART-PROWER FACTOR, HUMAN;Blood-coagulation factor X
• CAS NO: 9001-29-0
• Molecular Weight: 0
• EINECS: 232-596-5
• Mol File: 9001-29-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -20°C
• CAS DataBase Reference: ANTIHEMOPHILIC FACTOR C, HUMAN(CAS DataBase Reference)
• NIST Chemistry Reference: ANTIHEMOPHILIC FACTOR C, HUMAN(9001-29-0)
• EPA Substance Registry System: ANTIHEMOPHILIC FACTOR C, HUMAN(9001-29-0)

Safety Data

• Hazardous Substances Data: 9001-29-0(Hazardous Substances Data)

Usage

General Description

AntiheMophilic factor C, human is a medication used to replace factor VIII in patients with hemophilia A, a rare bleeding disorder. It contains a protein that is crucial for blood clotting and works by helping to prevent and control bleeding episodes in patients with hemophilia A. This medication is typically administered through intravenous injection and is essential for those with hemophilia A to prevent and manage bleeding episodes, especially in the event of surgery or injury. Side effects may include allergic reactions, headache, and fever, and it is important for patients to be monitored for the development of inhibitors to the medication. Overall, antiheMophilic factor C, human is an important and potentially life-saving treatment for those with hemophilia A.